bosentan anhydrous has been researched along with Diathesis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kinoshita, H; Yoshifuji, H | 1 |
| Cumming, AD; Firth, JD; Mullins, JJ; Veniant, MM; Whitworth, CE | 1 |
1 review(s) available for bosentan anhydrous and Diathesis
| Article | Year |
|---|---|
[Management of borderline pulmonary arterial hypertension associated with connective tissue diseases].
Topics: Antihypertensive Agents; Bosentan; Connective Tissue Diseases; Disease Susceptibility; Diuretics; Early Diagnosis; Humans; Hypertension, Pulmonary; Immunosuppressive Agents; Nitric Oxide Synthase Type II; Polymorphism, Genetic; Scleroderma, Systemic; Sulfonamides; Vasodilator Agents | 2014 |
1 other study(ies) available for bosentan anhydrous and Diathesis
| Article | Year |
|---|---|
Endothelin in the kidney in malignant phase hypertension.
Topics: Animals; Autoradiography; Blood Pressure; Bosentan; Disease Susceptibility; Endothelins; Gene Expression; Hypertension; Hypertension, Malignant; Kidney; Male; Mice; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; RNA; RNA, Messenger; Sulfonamides; Swine | 1995 |